REGENXBIO Gestion
Gestion contrôle des critères 2/4
Le PDG REGENXBIO est Curran Simpson, nommé en Jul2024, a un mandat de moins d'un an. La rémunération annuelle totale est $ 2.95M, composée du salaire de 17.4% et des bonus 82.6%, y compris les actions et options de la société. détient directement 0.031% des actions de la société, d'une valeur de $ 147.29K. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 5.9 ans et 7.4 ans.
Informations clés
Curran Simpson
Directeur général
US$3.0m
Rémunération totale
| Pourcentage du salaire du PDG | 17.4% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.03% |
| Durée moyenne d'occupation des postes de direction | 5.9yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 7.4yrs |
Mises à jour récentes de la gestion
Recent updates
REGENXBIO: With Additional MPS II Data, Program Advancement Remains On Track
Oct 31Does REGENXBIO (NASDAQ:RGNX) Have A Healthy Balance Sheet?
Sep 12
Regenxbio: RGX-121 Could Achieve A First For Rare Neurodegenerative Disorder
Aug 06REGENXBIO Inc. (NASDAQ:RGNX) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year
Aug 04Revenues Working Against REGENXBIO Inc.'s (NASDAQ:RGNX) Share Price
Jul 26Regenxbio: Transforming Gene Therapy With Innovative AAV Treatments, Strong Buy
Jun 11REGENXBIO Inc. (NASDAQ:RGNX) Analysts Are Cutting Their Estimates: Here's What You Need To Know
May 11REGENXBIO Inc. (NASDAQ:RGNX) Not Doing Enough For Some Investors As Its Shares Slump 26%
Apr 25Regenxbio: DMD Program Lends Additional Credibility To NAV Technology Platform
Mar 11Analysts Just Slashed Their REGENXBIO Inc. (NASDAQ:RGNX) EPS Numbers
Mar 07Improved Revenues Required Before REGENXBIO Inc. (NASDAQ:RGNX) Stock's 75% Jump Looks Justified
Mar 05Earnings Update: REGENXBIO Inc. (NASDAQ:RGNX) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts
Mar 02Regenxbio: Robust Data, Decent Cash, Never Ending Trials, Buying At Dips
Jan 19There's No Escaping REGENXBIO Inc.'s (NASDAQ:RGNX) Muted Revenues
Dec 21We Think REGENXBIO (NASDAQ:RGNX) Needs To Drive Business Growth Carefully
Nov 09Will REGENXBIO (NASDAQ:RGNX) Spend Its Cash Wisely?
Aug 08REGENXBIO Inc. (NASDAQ:RGNX) Analysts Just Trimmed Their Revenue Forecasts By 12%
May 11Here's Why We're Watching REGENXBIO's (NASDAQ:RGNX) Cash Burn Situation
May 08Analysts Are More Bearish On REGENXBIO Inc. (NASDAQ:RGNX) Than They Used To Be
Mar 05Analyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$239m |
| Jun 30 2024 | n/a | n/a | -US$241m |
| Mar 31 2024 | n/a | n/a | -US$260m |
| Dec 31 2023 | US$3m | US$513k | -US$263m |
| Sep 30 2023 | n/a | n/a | -US$261m |
| Jun 30 2023 | n/a | n/a | -US$274m |
| Mar 31 2023 | n/a | n/a | -US$270m |
| Dec 31 2022 | US$2m | US$475k | -US$280m |
| Sep 30 2022 | n/a | n/a | US$74m |
| Jun 30 2022 | n/a | n/a | US$91m |
| Mar 31 2022 | n/a | n/a | US$101m |
| Dec 31 2021 | US$3m | US$448k | US$128m |
| Sep 30 2021 | n/a | n/a | -US$212m |
| Jun 30 2021 | n/a | n/a | -US$145m |
| Mar 31 2021 | n/a | n/a | -US$121m |
| Dec 31 2020 | US$2m | US$428k | -US$111m |
| Sep 30 2020 | n/a | n/a | -US$91m |
| Jun 30 2020 | n/a | n/a | -US$135m |
| Mar 31 2020 | n/a | n/a | -US$103m |
| Dec 31 2019 | US$2m | US$382k | -US$95m |
| Sep 30 2019 | n/a | n/a | -US$64m |
| Jun 30 2019 | n/a | n/a | -US$49m |
| Mar 31 2019 | n/a | n/a | -US$37m |
| Dec 31 2018 | US$2m | US$371k | US$100m |
| Sep 30 2018 | n/a | n/a | US$80m |
| Jun 30 2018 | n/a | n/a | US$78m |
| Mar 31 2018 | n/a | n/a | US$53m |
| Dec 31 2017 | US$912k | US$361k | -US$73m |
Rémunération vs marché: La rémunération totale de Curran ($USD 2.95M ) est supérieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 2.16M ).
Rémunération et revenus: La rémunération de Curran a augmenté alors que l'entreprise n'est pas rentable.
PDG
Curran Simpson (62 yo)
less than a year
Titularisation
US$2,950,002
Compensation
Mr. Curran M. Simpson, M.S., had been the Chief Operating Officer at REGENXBIO Inc. since January 2023 until July 01, 2024 and served as its Executive Vice President until July 01, 2024 and serves as its P...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$2.95m | 0.031% $ 147.3k | |
| Executive VP & Chief Scientific Officer | 7.7yrs | US$2.99m | 0.061% $ 288.2k | |
| Advisor | less than a year | US$2.62m | 0.38% $ 1.8m | |
| Executive VP & Chief Medical Officer | 5.6yrs | US$3.31m | 0% $ 0 | |
| Executive VP & CFO | less than a year | pas de données | pas de données | |
| Executive VP & Chief Legal Officer | 8.3yrs | US$3.44m | 0.046% $ 218.6k | |
| Chief Communications & People Officer | 7.1yrs | pas de données | pas de données | |
| Executive VP of Commercial Strategy & Operations | 6.3yrs | pas de données | pas de données |
5.9yrs
Durée moyenne de l'emploi
55yo
Âge moyen
Gestion expérimentée: L'équipe dirigeante de RGNX est chevronnée et expérimentée (5.9 années d'ancienneté moyenne).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| President | less than a year | US$2.95m | 0.031% $ 147.3k | |
| Independent Director | 9.1yrs | US$339.98k | 0.0061% $ 28.9k | |
| Independent Director | 3.2yrs | US$339.98k | 0.0061% $ 28.9k | |
| Independent Director | 9.5yrs | US$352.48k | 0.013% $ 62.3k | |
| Member of Scientific Advisor | no data | pas de données | pas de données | |
| Director | 15.8yrs | US$354.98k | 6.39% $ 30.3m | |
| Member of Scientific Advisor | no data | pas de données | pas de données | |
| Independent Director | 6.5yrs | US$327.48k | 0.0061% $ 28.9k | |
| Lead Independent Director | 8.3yrs | US$334.98k | 0.0061% $ 28.9k | |
| Independent Director | 3.2yrs | US$324.98k | 0.0061% $ 28.9k | |
| Chairman | 15.7yrs | US$5.92m | 0.63% $ 3.0m | |
| Independent Director | 2.4yrs | US$329.98k | 0.0040% $ 19.2k |
7.4yrs
Durée moyenne de l'emploi
69.5yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de RGNX sont considérés comme expérimentés (ancienneté moyenne 7.4 ans).